Trial intelligence / Profile preview

Pegfilgrastim vs Filgrastim in Lymphoma or Myeloma Post-Transplant

NCT00794261Phase 2Completed

Sponsor
Centre Léon Bérard
Start
Sep 2008
Primary completion
Jan 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of pegfilgrastim in febrile neutropenia (FN), sponsored by Centre Léon Bérard. Started Sep 2008; status: completed.

02

Drugs

pegfilgrastim
03

Conditions

febrile neutropenia (FN)

Beyond the preview

Go deeper on NCT00794261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00794261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call